Antliabio210

N/A

Report date: 2023/06/16 15:13:30
NME

Base Information

Drug NameAntliabio210
Drug Alias NameAntliabio210Antliabio-210
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic DiseasesCardiovascular DiseasesLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntlia Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesAntlia Bioscience Inc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesCardiovascular DiseasesLung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A